Host-Cell Proteins: Implications for Protein-Drug Efficacy - BioProcess InternationalBioProcess International

Host cell protein content is often identified as a critical quality attribute and is often used as a benchmark during biologics manufacturing.

Improved host cell protein analysis in monoclonal antibody products through ProteoMiner - ScienceDirect

Exploring sample preparation and data evaluation strategies for enhanced identification of host cell proteins in drug products of therapeutic antibodies and Fc-fusion proteins

Drivers, Opportunities, and Limits of Continuous Processing - BioProcess InternationalBioProcess International

Host-Cell Proteins: Implications for Protein-Drug Efficacy - BioProcess InternationalBioProcess International

PDF) Host cell protein profiling of commercial therapeutic protein drugs as a benchmark for monoclonal antibody-based therapeutic protein development

Best practices & strategies for biotherapeutics production using a stable scale-up process - Aragen Life Sciences

QA/QC Archives - Page 3 of 20 - BioProcess InternationalBioProcess International

Host cell protein removal from biopharmaceutical preparations: Towards the implementation of quality by design - ScienceDirect

Host cell receptor/molecules/factors as therapeutic targets for

Monitoring process-related impurities in biologics–host cell protein analysis

Host-Cell Protein Risk Management and Control During Bioprocess Development: A Consolidated Biotech Industry Review, Part 1 - BioProcess InternationalBioProcess International